Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr;9(4):1438-1441.
doi: 10.1016/j.jaip.2021.01.022. Epub 2021 Jan 30.

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World

Matthew Greenhawt  1 , Elissa M Abrams  2 , John Oppenheimer  3 , Timothy K Vander Leek  4 , Douglas P Mack  5 , Alexander G Singer  6 , Marcus Shaker  7
Affiliations
Editorial

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World

Matthew Greenhawt et al. J Allergy Clin Immunol Pract. 2021 Apr.
No abstract available

Keywords: Adverse effects; Anaphylaxis; COVID-19; Graded challenge; Parameter; Shared decision-making; Vaccine.

PubMed Disclaimer

Comment in

Comment on

References

    1. Banerji A., Wickner P.G., Saff R., Stone C.A., Robinson L.B., Long A.A. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and approach. J Allergy Clin Immunol Pract. 2021;9:1423–1437. - PMC - PubMed
    1. Castells M.C., Phillips E.J. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med. 2021;384:643–649. - PMC - PubMed
    1. Centers for Disease Control and Prevention Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States— Appendix B. Atlanta, GA: United States Centers for Disease Control and Prevention; 2020. Reviewed December 20, 2020. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinicalconsiderat... Available from:
    1. Medicines and Healthcare Products Regulatory Agency (UK). Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine. https://www.gov.uk/drug-safety-update/covid-19-vaccines-pfizer-slash-bio... Available from:
    1. Kelso J.M., Greenhawt M.J., Li J.T., Nicklas R.A., Bernstein D.I., Blessing-Moore J. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130:25–43. - PubMed